Early bird registration is open and closes May 2025. Register now

Search

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

Gilead’s inflammation team is focused on improving therapeutic options for the treatment of multiple inflammatory conditions through a comprehensive clinical trial program evaluating novel agents with the goal of advancing patient care.

Share This Partner / Exhibitor

Key dates

Registrations
Abstracts

More Partners / Exhibitors

Novartis

R-Pharm-400x400

R-Pharm

Mitsubishi Tanabe Pharma

Boehringer Ingelheim

IFPA

BMJ Group